News Quantified

OPK – opko health, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

OPKO Health (OPK) had its price target lowered by Barrington Research from $2.25 to $1.50. They now have an "outperform" rating on the stock.

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

OPKO Health Q4 Earnings Call Highlights [Yahoo! Finance]

OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript [Seeking Alpha]

OPKO Health: Q4 Earnings Snapshot [Yahoo! Finance]

0.0%

BEAT

2.1%

BEAT

-7.0%

MISS

0.0%

MISS

Barrington Research

Form 10-K OPKO HEALTH, INC. For: Dec 31

Form 8-K OPKO HEALTH, INC. For: Feb 26

Top News Gainers

3/5 OPKO Health's BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test 29.2%

4/20 Form 4 Opko Health, Inc. For: Apr 17 Filed by: FROST PHILLIP MD ET AL 16.5%

3/17 OPKO Health's BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19) 13.1%

3/4 Form 4 Opko Health, Inc. For: Mar 03 Filed by: Frost Gamma Investments Trust 12.2%

3/13 Form 4 Opko Health, Inc. For: Mar 12 Filed by: Japour Anthony J 11.8%

4/6 Form 4 Opko Health, Inc. For: Apr 03 Filed by: FROST PHILLIP MD ET AL 11.6%

6/28 Novitas Issues Proposed Local Coverage Determination for the 4Kscore® Test 9.9%

4/8 Form 4 Opko Health, Inc. For: Apr 07 Filed by: Frost Gamma Investments Trust 7.8%

9/23 Form 8-K Opko Health, Inc. For: Sep 21 6.5%

3/10 Opko Health Inc. (NASDAQ: OPK) had its price target raised by analysts at Piper Sandler from to . 6.2%

Top News Decliners

3/9 Edited Transcript of OPK earnings conference call or presentation 26-Feb-20 9:30pm GMT [Yahoo! Finance News] -26.0%

5/7 Q1/2019 3/31/2019 EPS -0.140 ZacksConsensus -0.060 ActVsEst (0.080) - Miss -14.3%

10/24 OPKO Health, Inc. Announces Pricing of its Offering of Common Stock -14.3%

10/24 Form 424B5 Opko Health, Inc. -14.2%

3/13 Coronavirus activity roundup - healthcare [Seeking Alpha] -11.6%

3/7 Opko Health Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at Piper Sandler. -10.5%

3/20 Form 4 Opko Health, Inc. For: Mar 19 Filed by: Frost Gamma Investments Trust -8.5%

10/21 OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency -7.8%

11/5 OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results -7.5%

5/13 Form 4 Opko Health, Inc. For: May 10 Filed by: FROST PHILLIP MD ET AL -6.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day